PreveCeutical Medical Inc (18H) — Cash Flow Reinvestment Rate

Latest as of September 2021: 0.00x

PreveCeutical Medical Inc (18H) has a Cash Flow Reinvestment Rate of 0.00x as of September 2021, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €231.85K. Explore how much does PreveCeutical Medical Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

€0.00
Capex + Investments

Operating Cash Flow

€231.85K
EUR

Capital Expenditures

€0.00
EUR

PreveCeutical Medical Inc Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for PreveCeutical Medical Inc across 1 annual periods. Also explore 18H total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for PreveCeutical Medical Inc (2020–2020)

Year-by-year capital reinvestment analysis for PreveCeutical Medical Inc. For live market cap and broader valuation context, see 18H company net worth.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2020 0.08x €5.30K €64.59K €2.65K —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow